vs
ALLEGRO MICROSYSTEMS, INC.（ALGM）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
ALLEGRO MICROSYSTEMS, INC.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$229.2M vs $207.3M），ALLEGRO MICROSYSTEMS, INC.净利率更高（3.6% vs -62.0%，领先65.6%），ALLEGRO MICROSYSTEMS, INC.同比增速更快（28.9% vs 25.9%），ALLEGRO MICROSYSTEMS, INC.自由现金流更多（$41.3M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -2.4%）
Allegro微系统是一家全球性半导体设计制造企业，专注于研发生产高性能功率与传感类集成电路，核心产品覆盖磁传感器、功率IC、运动控制解决方案，广泛服务于汽车、工业、消费电子、通信等下游领域。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ALGM vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $229.2M | $207.3M |
| 净利润 | $8.3M | $-128.6M |
| 毛利率 | 46.7% | — |
| 营业利润率 | 4.2% | -54.7% |
| 净利率 | 3.6% | -62.0% |
| 营收同比 | 28.9% | 25.9% |
| 净利润同比 | 221.0% | 3.5% |
| 每股收益（稀释后） | $0.04 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $229.2M | $207.3M | ||
| Q3 25 | $214.3M | $159.9M | ||
| Q2 25 | $203.4M | $166.5M | ||
| Q1 25 | $192.8M | $139.3M | ||
| Q4 24 | $177.9M | $164.6M | ||
| Q3 24 | $187.4M | $139.5M | ||
| Q2 24 | $166.9M | $147.0M | ||
| Q1 24 | $240.6M | $108.8M |
| Q4 25 | $8.3M | $-128.6M | ||
| Q3 25 | $6.5M | $-180.4M | ||
| Q2 25 | $-13.2M | $-115.0M | ||
| Q1 25 | $-14.8M | $-151.1M | ||
| Q4 24 | $-6.9M | $-133.2M | ||
| Q3 24 | $-33.7M | $-133.5M | ||
| Q2 24 | $-17.7M | $-131.6M | ||
| Q1 24 | $-7.1M | $-170.7M |
| Q4 25 | 46.7% | — | ||
| Q3 25 | 46.3% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 41.4% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | 45.7% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 51.2% | — |
| Q4 25 | 4.2% | -54.7% | ||
| Q3 25 | 2.9% | -106.9% | ||
| Q2 25 | -1.3% | -64.8% | ||
| Q1 25 | -6.8% | -102.6% | ||
| Q4 24 | -0.0% | -74.3% | ||
| Q3 24 | 2.2% | -94.6% | ||
| Q2 24 | -6.4% | -79.1% | ||
| Q1 24 | 6.6% | -151.9% |
| Q4 25 | 3.6% | -62.0% | ||
| Q3 25 | 3.0% | -112.8% | ||
| Q2 25 | -6.5% | -69.0% | ||
| Q1 25 | -7.7% | -108.5% | ||
| Q4 24 | -3.9% | -80.9% | ||
| Q3 24 | -18.0% | -95.7% | ||
| Q2 24 | -10.6% | -89.5% | ||
| Q1 24 | -3.0% | -156.8% |
| Q4 25 | $0.04 | $-1.28 | ||
| Q3 25 | $0.03 | $-1.81 | ||
| Q2 25 | $-0.07 | $-1.17 | ||
| Q1 25 | $-0.08 | $-1.57 | ||
| Q4 24 | $-0.04 | $-1.34 | ||
| Q3 24 | $-0.18 | $-1.40 | ||
| Q2 24 | $-0.09 | $-1.52 | ||
| Q1 24 | $-0.04 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $155.2M | $421.0M |
| 总债务越低越好 | $280.7M | — |
| 股东权益账面价值 | $962.7M | $-80.0M |
| 总资产 | $1.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.29× | — |
8季度趋势，按日历期对齐
| Q4 25 | $155.2M | $421.0M | ||
| Q3 25 | $117.5M | $202.5M | ||
| Q2 25 | $129.1M | $176.3M | ||
| Q1 25 | $121.3M | $127.1M | ||
| Q4 24 | $138.5M | $174.0M | ||
| Q3 24 | $188.8M | $150.6M | ||
| Q2 24 | $173.1M | $480.7M | ||
| Q1 24 | $212.1M | $112.3M |
| Q4 25 | $280.7M | — | ||
| Q3 25 | $280.4M | — | ||
| Q2 25 | $304.8M | — | ||
| Q1 25 | $338.9M | — | ||
| Q4 24 | $368.7M | — | ||
| Q3 24 | $393.0M | — | ||
| Q2 24 | $195.8M | — | ||
| Q1 24 | $245.1M | — |
| Q4 25 | $962.7M | $-80.0M | ||
| Q3 25 | $944.2M | $9.2M | ||
| Q2 25 | $922.7M | $151.3M | ||
| Q1 25 | $929.6M | $144.2M | ||
| Q4 24 | $933.0M | $255.0M | ||
| Q3 24 | $937.3M | $346.8M | ||
| Q2 24 | $1.1B | $432.4M | ||
| Q1 24 | $1.1B | $140.3M |
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | 0.29× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.36× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.18× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $41.3M | $-100.8M |
| 自由现金流率自由现金流/营收 | 18.0% | -48.6% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 5.47× | — |
| 过去12个月自由现金流最近4个季度 | $121.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $45.4M | $-99.8M | ||
| Q3 25 | $20.4M | $-91.4M | ||
| Q2 25 | $61.6M | $-108.3M | ||
| Q1 25 | $20.4M | $-166.5M | ||
| Q4 24 | $-8.2M | $-79.3M | ||
| Q3 24 | $15.5M | $-67.0M | ||
| Q2 24 | $34.2M | $-77.0M | ||
| Q1 24 | $12.8M | $-190.7M |
| Q4 25 | $41.3M | $-100.8M | ||
| Q3 25 | $13.9M | $-92.7M | ||
| Q2 25 | $51.0M | $-110.7M | ||
| Q1 25 | $15.0M | $-167.8M | ||
| Q4 24 | $-21.8M | $-79.5M | ||
| Q3 24 | $5.6M | $-68.6M | ||
| Q2 24 | $23.2M | $-79.0M | ||
| Q1 24 | $-1.5M | $-193.9M |
| Q4 25 | 18.0% | -48.6% | ||
| Q3 25 | 6.5% | -58.0% | ||
| Q2 25 | 25.1% | -66.5% | ||
| Q1 25 | 7.8% | -120.5% | ||
| Q4 24 | -12.3% | -48.3% | ||
| Q3 24 | 3.0% | -49.2% | ||
| Q2 24 | 13.9% | -53.7% | ||
| Q1 24 | -0.6% | -178.2% |
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 3.0% | 0.8% | ||
| Q2 25 | 5.2% | 1.5% | ||
| Q1 25 | 2.8% | 1.0% | ||
| Q4 24 | 7.7% | 0.1% | ||
| Q3 24 | 5.3% | 1.2% | ||
| Q2 24 | 6.6% | 1.4% | ||
| Q1 24 | 5.9% | 3.0% |
| Q4 25 | 5.47× | — | ||
| Q3 25 | 3.12× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGM
| Automotive End Market | $164.5M | 72% |
| Industrial And Other End Market | $64.7M | 28% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
